Does the media prefer RCEL or KIDS?

In the previous week, OrthoPediatrics had 1 more articles in the media than Avita Medical. MarketBeat recorded 2 mentions for OrthoPediatrics and 1 mentions for Avita Medical. Avita Medical's average media sentiment score of 0.00 equaled OrthoPediatrics'average media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Avita Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral OrthoPediatrics 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to RCEL or CLPT?

In the previous week, ClearPoint Neuro had 3 more articles in the media than Avita Medical. MarketBeat recorded 4 mentions for ClearPoint Neuro and 1 mentions for Avita Medical. ClearPoint Neuro's average media sentiment score of 0.86 beat Avita Medical's score of 0.00 indicating that ClearPoint Neuro is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Avita Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral ClearPoint Neuro 1 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor RCEL or SI?

In the previous week, Shoulder Innovations had 2 more articles in the media than Avita Medical. MarketBeat recorded 3 mentions for Shoulder Innovations and 1 mentions for Avita Medical. Avita Medical's average media sentiment score of 0.00 beat Shoulder Innovations' score of -0.71 indicating that Avita Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Avita Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Shoulder Innovations 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Negative

Is CV or RCEL more profitable?

Avita Medical has a net margin of -62.67% compared to CapsoVision's net margin of -198.87%. Company Net Margins Return on Equity Return on Assets CapsoVision -198.87% N/A -136.03% Avita Medical -62.67% N/A -78.92%

Avita Medical (RCEL) Competitors

$4.01 0.00 (0.00%)

Closing price 06/18/2026 04:00 PM Eastern

Extended Trading

$4.03 +0.02 (+0.37%)

As of 06/18/2026 07:03 PM Eastern

Compare

RCEL vs. KIDS, DCTH, CLPT, SI, and CV

Should you buy Avita Medical stock or one of its competitors? MarketBeat compares Avita Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Avita Medical include OrthoPediatrics (KIDS), Delcath Systems (DCTH), ClearPoint Neuro (CLPT), Shoulder Innovations (SI), and CapsoVision (CV). These companies are all part of the "medical equipment" industry.

How does Avita Medical compare to OrthoPediatrics?

Avita Medical (NASDAQ:RCEL) and OrthoPediatrics (NASDAQ:KIDS) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, valuation, media sentiment, earnings, analyst recommendations, risk, institutional ownership and dividends.

OrthoPediatrics has a net margin of -16.31% compared to Avita Medical's net margin of -62.67%. Avita Medical's return on equity of 0.00% beat OrthoPediatrics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avita Medical	-62.67%	N/A	-78.92%
OrthoPediatrics	-16.31%	-7.01%	-4.86%

OrthoPediatrics has higher revenue and earnings than Avita Medical. OrthoPediatrics is trading at a lower price-to-earnings ratio than Avita Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avita Medical	$71.61M	1.72	-$48.59M	-$1.57	N/A
OrthoPediatrics	$236.35M	2.05	-$39.65M	-$1.68	N/A

27.7% of Avita Medical shares are held by institutional investors. Comparatively, 69.1% of OrthoPediatrics shares are held by institutional investors. 2.8% of Avita Medical shares are held by insiders. Comparatively, 32.7% of OrthoPediatrics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Avita Medical has a beta of 1.87, meaning that its share price is 87% more volatile than the broader market. Comparatively, OrthoPediatrics has a beta of 1.03, meaning that its share price is 3% more volatile than the broader market.

Avita Medical presently has a consensus price target of $7.25, suggesting a potential upside of 80.80%. OrthoPediatrics has a consensus price target of $24.44, suggesting a potential upside of 29.54%. Given Avita Medical's higher possible upside, equities research analysts clearly believe Avita Medical is more favorable than OrthoPediatrics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avita Medical	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33
OrthoPediatrics	1 Sell rating(s)	1 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.73

In the previous week, OrthoPediatrics had 1 more articles in the media than Avita Medical. MarketBeat recorded 2 mentions for OrthoPediatrics and 1 mentions for Avita Medical. Avita Medical's average media sentiment score of 0.00 equaled OrthoPediatrics'average media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Avita Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
OrthoPediatrics	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

OrthoPediatrics beats Avita Medical on 10 of the 15 factors compared between the two stocks.

How does Avita Medical compare to Delcath Systems?

Delcath Systems (NASDAQ:DCTH) and Avita Medical (NASDAQ:RCEL) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, risk, dividends, valuation, media sentiment and earnings.

Delcath Systems has a beta of 0.54, meaning that its share price is 46% less volatile than the broader market. Comparatively, Avita Medical has a beta of 1.87, meaning that its share price is 87% more volatile than the broader market.

Delcath Systems has a net margin of 0.62% compared to Avita Medical's net margin of -62.67%. Delcath Systems' return on equity of 0.51% beat Avita Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Delcath Systems	0.62%	0.51%	0.46%
Avita Medical	-62.67%	N/A	-78.92%

Delcath Systems presently has a consensus price target of $22.50, suggesting a potential upside of 92.47%. Avita Medical has a consensus price target of $7.25, suggesting a potential upside of 80.80%. Given Delcath Systems' stronger consensus rating and higher probable upside, analysts plainly believe Delcath Systems is more favorable than Avita Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Delcath Systems	2 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.43
Avita Medical	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33

61.1% of Delcath Systems shares are held by institutional investors. Comparatively, 27.7% of Avita Medical shares are held by institutional investors. 19.4% of Delcath Systems shares are held by insiders. Comparatively, 2.8% of Avita Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, Avita Medical had 1 more articles in the media than Delcath Systems. MarketBeat recorded 1 mentions for Avita Medical and 0 mentions for Delcath Systems. Delcath Systems' average media sentiment score of 0.00 equaled Avita Medical'saverage media sentiment score.

Company	Overall Sentiment
Delcath Systems	Neutral
Avita Medical	Neutral

Delcath Systems has higher revenue and earnings than Avita Medical. Avita Medical is trading at a lower price-to-earnings ratio than Delcath Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Delcath Systems	$85.23M	4.73	$2.70M	$0.01	1,169.00
Avita Medical	$71.61M	1.72	-$48.59M	-$1.57	N/A

Summary

Delcath Systems beats Avita Medical on 13 of the 15 factors compared between the two stocks.

How does Avita Medical compare to ClearPoint Neuro?

Avita Medical (NASDAQ:RCEL) and ClearPoint Neuro (NASDAQ:CLPT) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, valuation, profitability, earnings, institutional ownership, analyst recommendations, risk and media sentiment.

Avita Medical presently has a consensus price target of $7.25, indicating a potential upside of 80.80%. ClearPoint Neuro has a consensus price target of $23.00, indicating a potential upside of 29.43%. Given Avita Medical's higher possible upside, equities analysts plainly believe Avita Medical is more favorable than ClearPoint Neuro.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avita Medical	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33
ClearPoint Neuro	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

In the previous week, ClearPoint Neuro had 3 more articles in the media than Avita Medical. MarketBeat recorded 4 mentions for ClearPoint Neuro and 1 mentions for Avita Medical. ClearPoint Neuro's average media sentiment score of 0.86 beat Avita Medical's score of 0.00 indicating that ClearPoint Neuro is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Avita Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
ClearPoint Neuro	1 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

27.7% of Avita Medical shares are owned by institutional investors. Comparatively, 30.1% of ClearPoint Neuro shares are owned by institutional investors. 2.8% of Avita Medical shares are owned by company insiders. Comparatively, 6.9% of ClearPoint Neuro shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Avita Medical has a net margin of -62.67% compared to ClearPoint Neuro's net margin of -71.57%. Avita Medical's return on equity of 0.00% beat ClearPoint Neuro's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avita Medical	-62.67%	N/A	-78.92%
ClearPoint Neuro	-71.57%	-140.96%	-36.98%

Avita Medical has a beta of 1.87, suggesting that its share price is 87% more volatile than the broader market. Comparatively, ClearPoint Neuro has a beta of 1.31, suggesting that its share price is 31% more volatile than the broader market.

ClearPoint Neuro has lower revenue, but higher earnings than Avita Medical. ClearPoint Neuro is trading at a lower price-to-earnings ratio than Avita Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avita Medical	$71.61M	1.72	-$48.59M	-$1.57	N/A
ClearPoint Neuro	$36.97M	14.41	-$25.54M	-$1.01	N/A

Summary

ClearPoint Neuro beats Avita Medical on 8 of the 15 factors compared between the two stocks.

How does Avita Medical compare to Shoulder Innovations?

Avita Medical (NASDAQ:RCEL) and Shoulder Innovations (NYSE:SI) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, media sentiment, dividends, earnings, valuation, profitability, risk and institutional ownership.

27.7% of Avita Medical shares are owned by institutional investors. 2.8% of Avita Medical shares are owned by company insiders. Comparatively, 29.0% of Shoulder Innovations shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, Shoulder Innovations had 2 more articles in the media than Avita Medical. MarketBeat recorded 3 mentions for Shoulder Innovations and 1 mentions for Avita Medical. Avita Medical's average media sentiment score of 0.00 beat Shoulder Innovations' score of -0.71 indicating that Avita Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Avita Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Shoulder Innovations	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Negative

Avita Medical presently has a consensus price target of $7.25, suggesting a potential upside of 80.80%. Shoulder Innovations has a consensus price target of $21.00, suggesting a potential upside of 12.66%. Given Avita Medical's higher possible upside, research analysts plainly believe Avita Medical is more favorable than Shoulder Innovations.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avita Medical	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33
Shoulder Innovations	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57

Avita Medical has a net margin of -62.67% compared to Shoulder Innovations' net margin of -81.78%. Avita Medical's return on equity of 0.00% beat Shoulder Innovations' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avita Medical	-62.67%	N/A	-78.92%
Shoulder Innovations	-81.78%	-35.11%	-20.58%

Shoulder Innovations has lower revenue, but higher earnings than Avita Medical. Avita Medical is trading at a lower price-to-earnings ratio than Shoulder Innovations, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avita Medical	$71.61M	1.72	-$48.59M	-$1.57	N/A
Shoulder Innovations	$47.32M	8.17	-$40.36M	-$166.96	N/A

Summary

Shoulder Innovations beats Avita Medical on 8 of the 15 factors compared between the two stocks.

How does Avita Medical compare to CapsoVision?

CapsoVision (NASDAQ:CV) and Avita Medical (NASDAQ:RCEL) are both small-cap medical equipment companies, but which is the better business? We will compare the two companies based on the strength of their dividends, media sentiment, institutional ownership, profitability, earnings, analyst recommendations, valuation and risk.

27.7% of Avita Medical shares are owned by institutional investors. 2.3% of CapsoVision shares are owned by insiders. Comparatively, 2.8% of Avita Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, Avita Medical had 1 more articles in the media than CapsoVision. MarketBeat recorded 1 mentions for Avita Medical and 0 mentions for CapsoVision. CapsoVision's average media sentiment score of 0.00 equaled Avita Medical'saverage media sentiment score.

Company	Overall Sentiment
CapsoVision	Neutral
Avita Medical	Neutral

CapsoVision currently has a consensus target price of $8.50, suggesting a potential upside of 28.59%. Avita Medical has a consensus target price of $7.25, suggesting a potential upside of 80.80%. Given Avita Medical's higher possible upside, analysts clearly believe Avita Medical is more favorable than CapsoVision.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CapsoVision	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50
Avita Medical	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33

CapsoVision has higher earnings, but lower revenue than Avita Medical. CapsoVision is trading at a lower price-to-earnings ratio than Avita Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CapsoVision	$13.55M	24.37	-$25.32M	-$2.34	N/A
Avita Medical	$71.61M	1.72	-$48.59M	-$1.57	N/A

Avita Medical has a net margin of -62.67% compared to CapsoVision's net margin of -198.87%.

Company	Net Margins	Return on Equity	Return on Assets
CapsoVision	-198.87%	N/A	-136.03%
Avita Medical	-62.67%	N/A	-78.92%

Summary

Avita Medical beats CapsoVision on 10 of the 14 factors compared between the two stocks.

Get Avita Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RCEL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

RCEL vs. The Competition

Export

Metric	Avita Medical	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$123.42M	$2.98B	$6.42B	$12.59B
Dividend Yield	N/A	1.78%	2.68%	5.81%
P/E Ratio	-2.55	18.67	24.78	24.44
Price / Sales	1.72	455.43	554.02	122.73
Price / Cash	N/A	56.42	45.07	55.09
Price / Book	-7.29	4.04	10.80	6.58
Net Income	-$48.59M	$75.79M	$3.57B	$337.17M
7 Day Performance	2.56%	0.38%	0.72%	0.83%
1 Month Performance	-10.49%	-0.14%	0.41%	2.25%
1 Year Performance	-22.44%	26.02%	29.34%	36.14%

Avita Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
RCEL Avita Medical	3.0915 of 5 stars	$4.01 flat	$7.25 +80.8%	-22.4%	$123.42M	$71.61M	N/A	130	News Coverage Positive News
KIDS OrthoPediatrics	2.3061 of 5 stars	$18.49 +3.7%	$24.44 +32.2%	-7.0%	$472.41M	$236.35M	N/A	200	Gap Down
DCTH Delcath Systems	2.2875 of 5 stars	$11.90 +0.9%	$22.50 +89.1%	-15.6%	$410.62M	$85.23M	1,189.50	60	Gap Up
CLPT ClearPoint Neuro	2.7118 of 5 stars	$13.60 +0.6%	$18.00 +32.3%	+57.8%	$407.89M	$36.97M	N/A	110	News Coverage Analyst Forecast Options Volume
SI Shoulder Innovations	2.4993 of 5 stars	$18.64 +2.9%	$21.00 +12.7%	N/A	$386.57M	$47.32M	N/A	61	Insider Trade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:RCEL) was last updated on 6/21/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Avita Medical (RCEL) Competitors

RCEL vs. KIDS, DCTH, CLPT, SI, and CV

How does Avita Medical compare to OrthoPediatrics?

Summary

How does Avita Medical compare to Delcath Systems?

Summary

How does Avita Medical compare to ClearPoint Neuro?

Summary

How does Avita Medical compare to Shoulder Innovations?

Summary

How does Avita Medical compare to CapsoVision?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RCEL vs. The Competition

Avita Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Avita Medical (RCEL) Competitors

RCEL vs. KIDS, DCTH, CLPT, SI, and CV

How does Avita Medical compare to OrthoPediatrics?

Is RCEL or KIDS more profitable?

Which has preferable valuation & earnings, RCEL or KIDS?

Do insiders & institutionals hold more shares of RCEL or KIDS?

Which has more volatility & risk, RCEL or KIDS?

Do analysts rate RCEL or KIDS?

Does the media prefer RCEL or KIDS?

Summary

How does Avita Medical compare to Delcath Systems?

Which has more volatility & risk, DCTH or RCEL?

Is DCTH or RCEL more profitable?

Do analysts recommend DCTH or RCEL?

Do insiders and institutionals have more ownership in DCTH or RCEL?

Does the media favor DCTH or RCEL?

Which has better valuation and earnings, DCTH or RCEL?

Summary

How does Avita Medical compare to ClearPoint Neuro?

Do analysts rate RCEL or CLPT?

Does the media refer more to RCEL or CLPT?

Do institutionals & insiders believe in RCEL or CLPT?

Is RCEL or CLPT more profitable?

Which has more risk & volatility, RCEL or CLPT?

Which has preferable earnings & valuation, RCEL or CLPT?

Summary

How does Avita Medical compare to Shoulder Innovations?

Do institutionals and insiders hold more shares of RCEL or SI?

Does the media favor RCEL or SI?

Do analysts rate RCEL or SI?

Is RCEL or SI more profitable?

Which has better earnings & valuation, RCEL or SI?

Summary

How does Avita Medical compare to CapsoVision?

Do insiders and institutionals have more ownership in CV or RCEL?

Does the media favor CV or RCEL?

Do analysts recommend CV or RCEL?

Which has higher valuation and earnings, CV or RCEL?

Is CV or RCEL more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RCEL vs. The Competition

Avita Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools